| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |